KP Energy migrates to BSE from SME platform

Gujarat-based windmill infrastructure development K P Energy Limited Wednesday announced its migration to the BSE main board from the SME platform, after over two years of its getting listed on the bourse. The company's market cap stood at 261.15 crores on October 10.

"The company survived the turbulence in the industry in the past few years, (but) we are confident that there are better times ahead, and we are comfortably placed to monetise the benefits of the upswing in wind energy installations," said Farukbhai Patel, managing director, KP Energy.

The company reported a net profit of Rs 7.06 crore in HIFY19 as against Rs 1.01 crore in the same period of previous fiscal, thereby registering a whopping 599 per cent growth, it said. ***************** Lilly India enters autoimmune segment with Olumiant launch *
Olumiant (baricitinib) is a once-daily oral medication for the treatment of adults with moderate-to-severe active rheumatoid arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). Olumiant may be used as monotherapy or in combination with methotrexate. It will be available in India this month in 4mg and 2mg dosage forms. Olumiant is approved in more than 50 countries across the world, the release said. ****************** Saft India to accelerate growth plans *
Today, Saft employs 4,300 people in 18 countries. The company has research centers in France and the US, where it has a particularly strong footprint, and 14 manufacturing sites and 30 sales offices across the world. ************* Kritika Wires debuts on NSE Emerge Platform at 9.38% premium *